Home > Specialties > Stent/Grafts, Vascular, Aortoiliac

Stent/Grafts, Vascular, Aortoiliac

Definition : Stent/grafts designed for percutaneous deployment into the aorta and proximal sections of the iliac arteries. These devices are available in several shapes and materials. Some devices consist of an integral bifurcated (Y-shaped) graft with stents on its ends that includes a larger-diameter section for the aorta and two limbs for the iliac arteries. Other devices are modular systems with self-expanding stents that are inserted by parts - first, one part of the graft stent, including the aortic section and one iliac limb, is introduced through a femoral artery, then the contralateral limb is inserted from the opposite groin and attached to the previously inserted part. Most aortoiliac stent/grafts are used to bypass lower abdominal (under the renal artery) aortic aneurysms without a distal neck, usually also affecting the iliac arteries. Aortic stent/grafts divert the flow of blood away from the aneurysm wall, excluding the aneurysm from circulation. The procedure does not remove the aneurysm but allows it to shrink over time.

Entry Terms : "Iliac Stent/Grafts" , "Bifurcated Stent/Grafts" , "Y-Stent/Grafts" , "Aortoiliac Stent/Grafts" , "AAA Stent Grafts" , "Abdominal Aortic Aneurysm Stent Grafts" , "Endografts" , "Endovascular Grafts" , "Endovascular Stent Grafts" , "Grafts, Endovascular"

UMDC code : 20454

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Edwards Lifesciences Corp

Company Type: Parent

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.

Endologix Inc

Company Type: Parent

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA.

Medtronic Inc

Company Type: Parent

At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible.

1-3 of 3 Match(es).